Gene-nutrient interactions in cancer etiology

Nutrition Reviews

Volumn 62, Issue 11, 2004, Pages 427-438

  Nowell, Susan A ^a   Ahn, Jiyoung ^a   Ambrosone, Christine B ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CATALASE; HETEROCYCLIC AMINE; MANGANESE SUPEROXIDE DISMUTASE; MYELOPEROXIDASE;

BREAST CANCER; CANCER; CANCER RISK; CARCINOGENESIS; COLON CANCER; DIETARY INTAKE; EPIDEMIOLOGICAL DATA; FRUIT; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; NUTRIENT; OXIDATIVE STRESS; PHENOTYPE; PROSTATE CANCER; REVIEW; VEGETABLE;

CARCINOGENS; DIET; FRUIT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMIDAZOLES; MEAT; NEOPLASMS; NITROSAMINES; VEGETABLES;

EID: 9344227890     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1301/nr.2004.nov.427-438     Document Type: Review

References (142)

1. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 1981;66:1191-1308.
2. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer. 1975;15:617-631.
3. Haenszel W, Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst. 1968:40:43-68.
4. Buell P. Changing incidence of breast cancer in Japanese-American women. J Natl Cancer Inst. 1973;51:1479-1483.
5. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer. 1991;63:963-966.
6. Wynder EL, Mabuchi K, Whitmore WF Jr. Epidemiology of cancer of the prostate. Cancer. 1971;28: 344-360.
7. Potter JD. Nutrition and colorectal cancer. Cancer Causes Control. 1996;7:127-146.
8. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Speizer FE. Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med. 1990;323:1664-1672.
9. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Res. 1994;54:2390-2397.
10. Goldbohm RA, van den Brandt PA, van't Veer P, et al. A prospective cohort study on the relation between meat consumption and the risk of colon cancer. Cancer Res. 1994;54:718-723.
11. Chen J, Stampfer MJ, Hough HL, et al. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res. 1998;58:3307-3311.
12. Sandhu MS, White IR, McPherson K. Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-analytical approach. Cancer Epidemiol Biomarkers Prev. 2001;10:439-446.
13. Norat T, Lukanova A, Ferrari P, Riboli E. Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies. Int J Cancer. 2002;98:241-256.
14. Nagao M, Fujita Y, Wakabayashi K, Sugimura T. Ultimate forms of mutagenic and carcinogenic heterocyclic amines produced by pyrolysis. Biochem Biophys Res Commun. 1983;114:626-631.
15. Wakabayashi K, Nagao M, Esumi H, Sugimura T. Food-derived mutagens and carcinogens. Cancer Res. 1992;52(suppl 7):2092s-2098s.
16. Becher G, Knize MG, Nes IF, Felton JS. Isolation and identification of mutagens from a fried Norwegian meat product. Carcinogenesis. 1988;9:247-253.
17. Hatch FT, Knize MG, Healy SK, Slezak T, Felton JS. Cooked-Food Mutagen Reference List and Index. Environ Mol Mutagen. 1988;12(suppl. 14):1-85.
18. Knize MG, Shen NH, Felton JS. A comparison of mutagen production in fried ground chicken and beef: effect of supplemental creatine. Mutagenesis. 1988;3:503-508.
19. Minchin RF, Reeves PT, Teitel CH, et al. N- and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells. Biochem Biophys Res Commun. 1992;185: 839-844.
20. Chou HC, Lang NP, Kadlubar FF. Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s). Cancer Res. 1995;55:525-529.
21. Lang NP, Butler MA, Massengill J, et al. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol Biomarkers Prev. 1994;3:675-682.
22. Sachse C, Smith G, Wilkie MJ, et al. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis. 2002;23:1839-1849.
23. Le Marchand L, Hankin JH, Pierce LM, et al. Well-done red meat, metabolic phenotypes and colorectal cancer in Hawaii. Mutat Res. 2002;506-507: 205-214.
24. Ishibe N, Sinha R, Hein DW, et al. Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas. Pharmacogenetics. 2002;12:145-150.
25. Le Marchand L, Hankin JH, Wilkens LR, et al. Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2001;10:1259-1266.
26. Marchand LL. Combined influence of genetic and dietary factors on colorectal cancer incidence in Japanese Americans. J Natl Cancer Inst Monogr. 1999(26):101-105.
27. Sinha R, Rothman N, Salmon CP, Knize MG, Brown ED, Swanson CA, Rhodes D, Rossi S, Felton JS, Levander OA. Heterocyclic amine content in beef cooked by different methods to varying degrees of doneness and gravy made from meat drippings. Food Chem Toxicol. 1998;36:279-287.
28. Knize MG, Salmon CP, Pais P, Felton JS. Adv Exp Med Biol. 1999;459:179-193.
29. Knize MG, Kulp KS, Salmon CP, Keating GA, Felton JS. Factors affecting human heterocyclic amine intake and the metabolism of PhIP. Mutat Res. 2002;506-507:153-162.
30. Sinha R, Rothman N. Exposure assessment of heterocyclic amines (HCAs) in epidemiologic studies. Mutat Res. 1997;376:195-202.
31. Sinha R, Chow WH, Kulldorff M, et al. Well-done, grilled red meat increases the risk of colorectal adenomas. Cancer Res. 1999;59:4320-4324.
32. Butler LM, Sinha R, Millikan RC, et al. Heterocyclic amines, meat intake, and association with colon cancer in a population-based study. Am J Epidemiol. 2003;157:434-445.
33. Buonarati MH, Felton JS. Activation of 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP) to mutagenic metabolites. Carcinogenesis. 1990;11: 1133-1138.
34. Coles B, Ketterer B. The role of glutathione and glutathione transferases in chemical carcinogenesis. Crit Rev Biochem Mol Biol. 1990;25:47-70.
35. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family, regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995, 30:445-600.
36. Coles B, Nowell SA, MacLeod SL, Sweeney C, Lang NP, Kadlubar FF. The role of human glutathione S-transferases (hGSTs) in the detoxification of the food-derived carcinogen metabolite N-acetoxy-PhIP, and the effect of a polymorphism in hGSTA1 on colorectal cancer risk. Mutat Res. 2001;482:3-10.
37. Coles BF, Morel F, Rauch C, et al. Effect of polymorphism in the human glutathione S-transferase A1 (hGSTA1) promoter on hepatic GSTA1 and GSTA2 expression. Pharmacogenetics. 2001;11: 663-669.
38. Boyd NF, Martin LJ, Noffel M, Lockwood GA, Trichler DL. A meta-analysis of studies of dietary fat and breast cancer risk. Br J Cancer. 1993;68: 627-636.
39. Toniolo P, Riboli E, Shore RE, Pasternack BS. Consumption of meat, animal products, protein, and fat and risk of breast cancer. a prospective cohort study in New York. Epidemiology. 1994;5: 391-397.
40. Gaard M, Tretli S, Loken EB. Dietary fat and the risk of breast cancer. a prospective study of 25,892 Norwegian women. Int J Cancer. 1995;63: 13-17.
41. Vatten LJ, Solvoll K, Loken EB. Frequency of meat and fish intake and risk of breast cancer in a prospective study of 14,500 Norwegian women. Int J Cancer. 1990;46:12-15.
42. Ambrosone CB, Freudenheim JL, Sinha R, et al. Breast cancer risk, meat consumption and N-acetyltransferase (NAT2) genetic polymorphisms. Int J Cancer. 1998;75:825-830.
43. Deitz AC, Zheng W, Leff MA, et al. N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2000;9:905-910.
44. Kocabas NA, Sardas S, Cholerton S, Daly AK, Karakaya AE. N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility, a lack of association in a case-control study of Turkish population. Int J Toxicol. 2004;23:25-31.
45. Sinha R, Gustafson DR, Kulldorff M, Wen WQ, Cerhan JR, Zheng W. 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, a carcinogen in high-temperature-cooked meat, and breast cancer risk. J Natl Cancer Inst. 2000;92:1352-1354.
46. Zhu J, Chang P, Bondy ML, et al. Detection of 2-amino-1-methyl-6- phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2003;12:830-837.
47. DeBruin LS, Martos PA, Josephy PD. Detection of PhIP (2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine) in the milk of healthy women. Chem Res Toxicol. 2001;14:1523-1528.
48. Lightfoot TJ, Coxhead JM, Cupid BC, Nicholson S, Garner RC. Analysis of DNA adducts by accelerator mass spectrometry in human breast tissue after administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and benzo[a]pyrene. Mutat Res. 2000;472:119-127.
49. Gorlewska-Roberts K, Green B, Fares M, Ambrosone CB, Kadlubar FF. Carcinogen-DNA adducts in human breast epithelial cells. Environ Mol Mutagen. 2002, 39:184-192.
50. Platz EA, Rimm EB, Willett WC, Kantoff PW, Giovannucci E. Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. J Natl Cancer Inst. 2000;92:2009-2017.
51. Platz EA, Kawachi I, Rimm EB, Willett WC, Giovannucci E. Race, ethnicity and benign prostatic hyperplasia in the health professionals follow-up study. J Urol. 2000;163:490-495.
52. Muir CS, Nectoux J, Staszewski J. The epidemiology of prostatic cancer. Geographical distribution and time-trends. Acta Oncol. 1991, 30:133-140.
53. Prentice RL, Sheppard L. Dietary fat and cancer. consistency of the epidemiologic data, and disease prevention that may follow from a practical reduction in fat consumption. Cancer Causes Control. 1990;1:81-109.
54. Kolonel LN. Nutrition and prostate cancer. Cancer Causes Control. 1996;7:83-44.
55. Kolonel LN. Fat, meat, and prostate cancer. Epidemiol Rev. 2001;23:72-81.
56. Ross RK. Epidemiology of prostate cancer and bladder cancer. an overview. Cancer Treat Res. 1996;88:1-11.
57. Shirai T, Sano M, Tamano S, et al. The prostate. a target for carcinogenicity of. 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods. Cancer Res. 1997;57:195-198.
58. Williams JA, Martin FL, Muir GH, Hewer A, Graver PL, Phillips DH. Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue. Carcinogenesis. 2000; 21:1683-1689.
59. Cui L, Takahashi S, Tada M, et al. Immunohistochemical detection of carcinogen-DNA adducts in normal human prostate tissues transplanted into the subcutis of athymic nude mice results with 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine (PhIP) and 3,2′-dimethyl-4-aminobiphenyl (DMAB) and relation to cytochrome P450s and N-acetyltransferase activity. Jpn J Cancer Res. 2000;91: 52-58.
60. Norrish AE, Ferguson LR, Knize MG, Felton JS, Sharpe SJ, Jackson RT. Heterocyclic amine content of cooked meat and risk of prostate cancer. J Natl Cancer Inst. 1999;91:2038-2044.
61. Hein DW, Leff MA, Ishibe N, et al. Association of prostate cancer with rapid N-acetyltransferase. 1 (NAT1*10) in combination with slow N-acetyltransferase. 2 acetylator genotypes in a pilot case-control study. Environ Mol Mutagen. 2002;40:161-167.
62. Muckel E, Frandsen H, Glatt HR. Heterologous expression of human N-acetyltransferases 1 and 2 and sulfotransferase 1A1 in Salmonella typhimurium for mutagenicity testing of heterocyclic amines. Food Chem Toxicol. 2002;40:1063-1068.
63. Dooley TP, Haldeman-Cahill R, Joiner J, Wilborn TW. Expression profiling of human sulfotransferase and sulfatase gene superfamilies in epithelial tissues and cultured cells. Biochem Biophys Res Commun. 2000;277:236-245.
64. Ozawa S, Tang YM, Yamazoe Y, Kato R, Lang NP, Kadlubar FF. Genetic polymorphisms in human liver phenol sulfotransferases involved in the bio-activation of N-hydroxy derivatives of carcinogenic arylamines and heterocyclic amines. Chem Biol Interact. 1998;109:237-248.
65. Raftogianis RB, Wood TC, Otterness DM, Van Loon JA, Weinshilboum RM. Phenol sulfotransferase pharmacogenetics in humans association of common SULT1A1 alleles with TS PST phenotype. Biochem Biophys Res Commun. 1997;239: 298-304.
66. Steiner M, Bastian M, Schulz WA, et al. Phenol sulphotransferase SULT1A1 polymorphism in prostate cancer lack of association. Arch Toxicol. 2000;74:222-225.
67. Nowell S, Ratnasinghe DL, Ambrosone CB, et al. Association of SULT1A1 phenotype and genotype with prostate cancer risk in African-Americans and Caucasians. Cancer Epidemiol Biomarkers Prev. 2004;13:270-276.
68. Knekt P, Jarvinen R, Dich J, Hakulinen T. Risk of colorectal and other gastro-intestinal cancers after exposure to nitrate, nitrite and N-nitroso compounds, a follow-up study. Int J Cancer. 1999;80: 852-856.
69. Chao A, Thun MJ, Jacobs EJ, Henley SJ, Rodriguez C, Calle EE. Cigarette smoking and colorectal cancer mortality in the cancer prevention study II. J Natl Cancer Inst. 2000;92:1888-1896.
70. Norat T, Riboli E. Meat consumption and colorectal cancer. a review of epidemiologic evidence. Nutr Rev. 2001;59:37-47.
71. Knekt P, Jarvinen R, Dich J, Hakulinen T. Risk of colorectal and other gastro-intestinal cancers after exposure to nitrate, nitrite and N-nitroso compounds, a follow-up study. Int J Cancer. 1999;80: 852-856.
72. Le Marchand L, Donion T, Seifried A, Wilkens LR. Red meat intake. CYP2E1 genetic polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:1019-1024.
73. Nowell S, Sweeney C, Hammons G, Kadlubar FF, Lang NP. CYP2A6 activity determined by caffeine phenotyping association with colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2001;11: 377-383.
74. Glade MJ. Food, nutrition, and the prevention of cancer a global perspective. American Institute for Cancer Research/World Cancer Research Fund, 1997. Nutrition. 1999;15:523-526.
75. Fowke JH, Longcope C, Hebert JR. Brassica vegetable consumption shifts estrogen metabolism in healthy postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2000;9:773-779.
76. Talalay P, Fahey JW. Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J Nutr. 2001;131(suppl 11):3027S-3033S.
77. Michnovicz JJ, Bradlow HL. Dietary and pharmacological control of estradiol metabolism in humans. Ann N Y Acad Sci. 1990;595:291-299.
78. Yuan F, Chen DZ, Liu K, Sepkovic DW, Bradlow HL, Auborn K. Anti-estrogenic activities of indole-3-carbinol in cervical cells implication for prevention of cervical cancer. Anticancer Res. 1999;19: 1673-1680.
79. Meng Q, Yuan F, Goldberg ID, Rosen EM, Auborn K, Fan S. Indole-3-carbinol is a negative regulator of estrogen receptor-alpha signaling in human tumor cells. J Nutr. 2000;130:2927-2931.
80. Mannervik B, Awasthi YC, Board PG, et al. Nomenclature for human glutathione transferases. 1992;282:305-306.
81. Forrester LM, Hayes JD, Millis R, et al. Expression of glutathione S-transferases and cytochrome P450 in normal and tumor breast tissue. 1990;11: 2163-2170.
82. Brockmoller J, Gross D, Kerb R, Drakoulis N, Roots I. Correlation between trans-stilbene oxide-glutathione conjugation activity and the deletion mutation in the glutathione S-transferase class mu gene detected by polymerase chain reaction. Biochem Pharmacol. 1992;43:647-650.
83. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 1997;6:733-743.
84. Bailey LR, Roodi N, Verrier CS, Yee CJ, Dupont WD, Pari FF. Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms, evidence of a lack of association in Caucasians and African Americans. Cancer Res. 1998;58:65-70.
85. Helzlsouer KJ, Selmin O, Huang HY, et al. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst. 1998;90:512-518.
86. Kelsey KT, Hankinson SE, Colditz GA, et al. Glutathione S-transferase class mu deletion polymorphism and breast cancer. results from prevalent versus incident cases. Cancer Epidemiol Biomarkers Prev. 1997;6:511-515.
87. Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis. 1993;14:1821-1824.
88. Ambrosone CB, Coles BF, Freudenheim JL, Shields PG. Glutathione-S- transferase (GSTM1) genetic polymorphisms do not affect human breast cancer risk, regardless of dietary antioxidants. J Nutr. 1999;129(suppl 2S):565S-568S.
89. Ambrosone CB, Freudenheim JL, Graham S, et al. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res. 1995; 55:3483-3485.
90. Zheng W, Wen WQ, Gustafson DR, Gross M, Cerhan JR, Folsom AR. GSTM1 and GSTT1 polymorphisms and postmenopausal breast cancer risk. Breast Cancer Res Treat. 2002;74:9-16.
91. Ketterer B. Dietary isothiocyanates as confounding factors in the molecular epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev. 1998; 7:645-646.
92. London SJ, Yuan JM, Chung FL, et al. Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk. a prospective study of men in Shanghai, China. Lancet. 2000; 356:724-729.
93. Spitz MR, Duphorne CM, Detry MA, et al. Dietary intake of isothiocyanates evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2000;9:1017-1020.
94. Zhao B, Seow A, Lee EJ, et al. Dietary isothiocyanates, glutathione S-transferase -M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore. Cancer Epidemiol Biomarkers Prev. 2001;10:1063-1067.
95. Lin HJ, Probst-Hensch NM, Louie AD, et al. Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 1998;7:647-652.
96. Slattery ML, Kampman E, Samowitz W, Caan BJ, Potter JD. Interplay between dietary inducers of GST and the GSTM-1 genotype in colon cancer. Int J Cancer. 2000;87:728-733.
97. Ambrosone CB, McCann SE, Freudenheim JL, Marshall JR, Zhang Y, Shields PG. Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype. J Nutr. 2004;134:1134-1138.
98. Ambrosone CB. Oxidants and antioxidants in breast cancer. Antioxid Redox Signal. 2000;2:903-917.
99. Halliwell B. Lipid peroxidation, antioxidants and cardiovascular disease, how should we move forward? Cardiovasc Res. 2000;47:410-418.
100. Gandini S, Merzenich H, Robertson C, Boyle P. Meta-analysis of studies on breast cancer risk and diet. the role of fruit and vegetable consumption and the intake of associated micronutrients. Eur J Cancer. 2000, 36:636-646.
101. Howe GR, Hirohata T, Hislop TG, et al. Dietary factors and risk of breast cancer combined analysis of 12 case-control studies. J Natl Cancer Inst. 1990;82:561-569.
102. Riboli E, Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr. 2003;78(suppl 3):559S-569S.
103. Smith-Warner SA, Spiegelman D, Yaun SS, et al. Intake of fruits and vegetables and risk of breast cancer. a pooled analysis of cohort studies. JAMA. 2001;285:769-776.
104. Willett WC. Diet and breast cancer. J Intern Med. 2001;249:395-411.
105. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun. 1996;226:561-565.
106. Borgstahl GE, Parge HE, Hickey MJ, et al. Human mitochondrial manganese superoxide dismutase polymorphic variant IIe58Thr reduces activity by destabilizing the tetrameric interface. Biochemistry. 1996, 35:4287-4297.
107. Rohrdanz E, Kahl R. Alterations of antioxidant enzyme expression in response to hydrogen peroxide. Free Radic Biol Med. 1998;24:27-38.
108. Gilks CB, Price K, Wright JL, Churg A. Antioxidant gene expression in rat lung after exposure to cigarette smoke. Am J Pathol. 1998;152:269-278.
109. Rosenblum JS, Gilula NB, Lerner RA. On signal sequence polymorphisms and diseases of distribution. Proc Natl Acad Sci USA. 1996;93:4471-4473.
110. Ambrosone CB, Freudenheim JL, Thompson PA, et al. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res. 1999;59:602-606.
111. Mitrunen K, Sillanpaa P, Kataja V, et al. Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis. 2001;22:827-829.
112. Egan KM, Thompson PA, Titus-Ernstoff L, Moore JH, Ambrosone CB. MnSOD polymorphism and breast cancer in a population-based case-control study. Cancer Lett. 2003;199:27-33.
113. Hong YC, Lee KH, Yi CH, Ha EH, Christiani DC. Genetic susceptibility of term pregnant women to oxidative damage. Toxicol Lett. 2002;129:255-262.
114. Tamimi RM, Hankinson SE, Spiegelman D, Colditz GA, Hunter DJ. Manganese superoxide dismutase polymorphism, plasma antioxidants, cigarette smoking, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2004;13:989-996.
115. Woodson K, Tangrea JA, Lehman TA, et al. Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland). Cancer Causes Control. 2003;14:513-518.
116. Li H, Kantoff P, Giovannnucci E, Leitzmann MF, Gaziano M, Stampfer M. Manganese superoxide dismutase (MnSOD) polymorphism, prediagnostic plasma antioxidants and prostate cancer risk. In: Proceedings of the American Association for Cancer Research. Washington, DC: American Association for Cancer Research;2004:A2320.
117. Shull S, Heintz NH, Periasamy M, et al. Differential regulation of antioxidant enzymes in response to oxidants. J Biol Chem. 1991;266:24398-24403.
118. Tate DJ Jr, Miceli MV, Newsome DA. Phagocytosis and H2O2 induce catalase and metallothionein gene expression in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1995, 36: 1271-1279.
119. Ishii T, Aoki N, Noda A, Adachi T, Nakamura R, Matsuda T. Carboxy-terminal cytoplasmic domain of mouse butyrophilin specifically associates with a 150-kDa protein of mammary epithelial cells and milk fat globule membrane. Biochem Biophys Acta. 1995;1245:285-292.
120. Forsberg L, Lyrenas L, de Faire U, Morgenstern R. A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic Biol Med. 2001; 30:500-505.
121. Goulas A, Fidani L, Kotsis A, Mirtsou V, Petersen RC, Tangalos E, Hardy J. An association study of a functional catalase gene polymorphism, -262C→T, and patients with Alzheimer's disease. Neurosci Lett. 2002;330:210-213.
122. Ahsan H, Chen Y, Kibriya MG, et al. Susceptibility to arsenic-induced hyperkeratosis and oxidative stress genes myeloperoxidase and catalase. Cancer Lett. 2003;201:57-65.
123. Jiang Z, Akey JM, Shi J, et al. A polymorphism in the promoter region of catalase is associated with blood pressure levels. Hum Genet. 2001;109:95-98.
124. Ahn J, Gammon MD, Santella RM, et.al. Catalase (CAT) genotype, fruit and vegetable consumption, and breast cancer risk. In: Proceedings of the American Association for Cancer Research. Washington, DC: American Association for Cancer Research; 2004.
125. Klebanoff SJ. Oxygen metabolism and the toxic properties of phagocytes. Ann Intern Med. 1980; 93:480-489.
126. Josephy PD. The role of peroxidase-catalyzed activation of aromatic amines in breast cancer. Mutagenesis. 1996;11:3-7.
127. Samoszuk MK, Nguyen V, Gluzman I, Pham JH. Occult deposition of eosinophil peroxidase in a subset of human breast carcinomas. Am J Pathol. 1996;148:701-706.
128. Austin GE, Lam L, Zaki SR, et al. Sequence comparison of putative regulatory DNA of the 5′ flanking region of the myeloperoxidase gene in normal and leukemic bone marrow cells. Leukemia. 1993; 7:1445-1450.
129. London SJ, Lehman TA, Taylor JA. Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res. 1997;57:5001-5003.
130. Piedrafita FJ, Molander RB, Vansant G, Orlova EA, Pfahl M, Reynolds WF. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J Biol Chem. 1996;271:14412-14420.
131. Reynolds WF, Chang E, Douer D, Ball ED, Kanda V. An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia. Blood. 1997;90:2730-2737.
132. Van Schooten FJ, Boots AW, Knaapen AM, et al. Myeloperoxidase (MPO) -463G→A reduces MPO activity and DNA adduct levels in bronchoalveolar lavages of smokers. Cancer Epidemiol Biomarkers Prev. 2004;13:828-833.
133. Cascorbi I, Henning S, Brockmoller J, et al. Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant -463A of the myeloperoxidase gene. Cancer Res. 2000;60;644-649.
134. Feyler A, Voho A, Bouchardy C, et al. Point: myeloperoxidase -463G→A polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:1550-1554.
135. Le Marchand L, Seifried A, Lum A, Wilkens LR. Association of the myeloperoxidase -463G→A polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2000;9:181-184.
136. Schabath MB, Spitz MR, Zhang X, Delclos GL, Wu X. Genetic variants of myeloperoxidase and lung cancer risk. Carcinogenesis. 2000;21:1163-1166.
137. Xu LL, Liu G, Miller DP, et al. Counterpoint the myeloperoxidase -463G→A polymorphism does not decrease lung cancer susceptibility in Caucasians. Cancer Epidemiol Biomarkers Prev. 2002; 11:1555-1559.
138. Misra RR, Tangrea JA, Virtamo J, et al. Variation in the promoter region of the myeloperoxidase gene is not directly related to lung cancer risk among male smokers in Finland. Cancer Lett. 2001;164: 161-167.
139. Reynolds WF, Rhees J, Maciejewski D, et al. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease. Exp Neurol. 1999;155:31-41.
140. Bekesi G, Kakucs R, Varbiro S, et al. Induced myeloperoxidase activity and related superoxide inhibition during hormone replacement therapy. BJOG. 2001;108:474-481.
141. Marcozzi FG, Madia F, Del Bianco G, Mattei E, de Feo G. Lacrimal fluid peroxidase activity during the menstrual cycle. Curr Eye Res. 2000;20:178-182.
142. Ahn J, Gammon MD, Santella RM, et al. Myeloperoxidase genotype, fruit and vegetable consumption, and breast cancer risk. Cancer Res. 2004;64: 7634-7639.